BIOMAT Database Logo BIOMAT Database Logo

Vitamin D metabolism in familial benign hypercalcemia (hypocalciuric hypercalcemia) differs from that in primary hyperparathyroidism. 1984

W M Law, and S Bollman, and R Kumar, and H Heath

We compared serum concentrations of immunoreactive PTH and plasma levels of vitamin D metabolites in 11 patients with adenomatous primary hyperparathyroidism and 32 individuals with the syndrome of familial benign hypercalcemia or familial hypocalciuric hypercalcemia (FHH). Serum immunoreactive PTH was elevated in the hyperparathyroid group but indistinguishable from control in FHH, despite comparable degrees of hypercalcemia. Plasma 25-hydroxyvitamin D concentrations were normal in both groups, but plasma 1,25-dihydroxyvitamin D levels in FHH were significantly lower than control (P less than 0.0025) or hyperparathyroid (P less than 0.01) values. FHH is pathogenetically distinct from primary hyperparathyroidism and should not be thought of simply as a variant of that condition.

UI MeSH Term Description Entries
D006961 Hyperparathyroidism A condition of abnormally elevated output of PARATHYROID HORMONE (or PTH) triggering responses that increase blood CALCIUM. It is characterized by HYPERCALCEMIA and BONE RESORPTION, eventually leading to bone diseases. PRIMARY HYPERPARATHYROIDISM is caused by parathyroid HYPERPLASIA or PARATHYROID NEOPLASMS. SECONDARY HYPERPARATHYROIDISM is increased PTH secretion in response to HYPOCALCEMIA, usually caused by chronic KIDNEY DISEASES.
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010281 Parathyroid Hormone A polypeptide hormone (84 amino acid residues) secreted by the PARATHYROID GLANDS which performs the essential role of maintaining intracellular CALCIUM levels in the body. Parathyroid hormone increases intracellular calcium by promoting the release of CALCIUM from BONE, increases the intestinal absorption of calcium, increases the renal tubular reabsorption of calcium, and increases the renal excretion of phosphates. Natpara,PTH (1-84),PTH(1-34),Parathormone,Parathyrin,Parathyroid Hormone (1-34),Parathyroid Hormone (1-84),Parathyroid Hormone Peptide (1-34),Hormone, Parathyroid
D010758 Phosphorus A non-metal element that has the atomic symbol P, atomic number 15, and atomic weight 31. It is an essential element that takes part in a broad variety of biochemical reactions. Black Phosphorus,Phosphorus-31,Red Phosphorus,White Phosphorus,Yellow Phosphorus,Phosphorus 31,Phosphorus, Black,Phosphorus, Red,Phosphorus, White,Phosphorus, Yellow
D002118 Calcium A basic element found in nearly all tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes. Coagulation Factor IV,Factor IV,Blood Coagulation Factor IV,Calcium-40,Calcium 40,Factor IV, Coagulation
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006934 Hypercalcemia Abnormally high level of calcium in the blood. Milk-Alkali Syndrome,Hypercalcemias,Milk Alkali Syndrome,Syndrome, Milk-Alkali
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

W M Law, and S Bollman, and R Kumar, and H Heath
Differentiating familial hypocalciuric hypercalcemia from primary hyperparathyroidism.
January 2013, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists,
W M Law, and S Bollman, and R Kumar, and H Heath
Neonatal primary hyperparathyroidism in familial hypocalciuric hypercalcemia.
August 1982, American journal of diseases of children (1960),
W M Law, and S Bollman, and R Kumar, and H Heath
Divalent cation metabolism. Familial hypocalciuric hypercalcemia versus typical primary hyperparathyroidism.
August 1978, The American journal of medicine,
W M Law, and S Bollman, and R Kumar, and H Heath
Familial benign (hypocalciuric) hypercalcemia. A troublesome mimic of mild primary hyperparathyroidism.
September 1989, Endocrinology and metabolism clinics of North America,
W M Law, and S Bollman, and R Kumar, and H Heath
Benign familial hypocalciuric hypercalcemia.
January 2011, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists,
W M Law, and S Bollman, and R Kumar, and H Heath
Familial benign hypocalciuric hypercalcemia.
November 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research,
W M Law, and S Bollman, and R Kumar, and H Heath
[Familial benign hypercalcemia or familial hypocalciuric hypercalcemia].
January 1993, Annales de medecine interne,
W M Law, and S Bollman, and R Kumar, and H Heath
Primary hyperparathyroidism in infancy associated with familial hypocalciuric hypercalcemia.
July 1983, Acta paediatrica Scandinavica,
W M Law, and S Bollman, and R Kumar, and H Heath
Uncertainties in distinction of typical primary hyperparathyroidism from familial hypocalciuric hypercalcemia.
February 1982, The Western journal of medicine,
W M Law, and S Bollman, and R Kumar, and H Heath
Parathyroid glands in familial benign hypercalcemia (familial hypocalciuric hypercalcemia).
June 1984, The American journal of medicine,
Copied contents to your clipboard!